At the general assembly of swissethics, Ms. Dr. Susanne Driessen was confirmed and re-elected as President and Dr. iur. Jürg Müller as Vice President. Ms. Prof. Dr. Caroline Samer, currently Vice President of the Ethics Committee Geneva, was newly elected as Vice President.

The swissethics executive board of directors has decided, on the proposal of the lawyers of the Ethics Committees, that as of March 1, 2023, approvals for clinical trials and research projects will be limited to a period of five years. After five years, the ethics committee will decide whether the project can continue with the documents approved at that time or whether adjustments are necessary. Further details on this process will be communicated at a later date.